Safety and efficacy of conversion therapy for esophageal squamous cell carcinoma.

被引：0
|
作者：
Tsuji, Takayuki
Kawakubo, Hirofumi
Takeuchi, Masashi
Matsuda, Satoru
Fukuda, Kazumasa
Nakamura, Rieko
Kitagawa, Yuko
机构：
[1] Keio Univ, Sch Med, Shinjuku Ku, Tokyo, Japan
[2] Keio Univ, Div Gen & Gastroenterol Surg, Sch Med, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
362
引用
收藏
页码：362 / 362
页数：1
相关论文
共 50 条
  • [41] New aspects of the neo-adjuvant therapy in esophageal squamous cell carcinoma. A review of medical literature
    Tercioti, Valdir, Jr.
    Lopes, Luiz Roberto
    de Souza Coelho, Joao Neto
    Andreollo, Nelson Adami
    ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2009, 22 (01): : 33 - 40
  • [42] Efficacy of Enteral Access in Patients with Esophageal Squamous Cell Carcinoma Under Neoadjuvant Therapy
    Huang, Chun-Hou
    Wang, Tso-Fu
    Wu, Yi-Feng
    Cheng, Yi-Tso
    Lo, Shu-Fen
    Hsieh, Tsung-Cheng
    Peng, Tai-Chu
    ANTICANCER RESEARCH, 2018, 38 (12) : 6939 - 6945
  • [43] Gastric squamous cell carcinoma.
    Penaranda, JMS
    Santias, RMR
    Baltar, J
    Vila, JF
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1996, 88 (05) : 369 - 371
  • [44] Efficacy and safety of pembrolizumab in Chinese patients with recurrent/unresectable/metastatic head and neck squamous cell carcinoma.
    Li, Jieying
    Song, Kai
    Feng, Yuanyong
    Shang, Wei
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18001 - E18001
  • [45] Efficacy and Safety of Neoadjuvant Chemoimmunotherapy in Resectable Esophageal Squamous Cell Carcinoma: A Meta-analysis
    Xu, Jinxin
    Yan, Chun
    Li, Zhe
    Cao, Yunpeng
    Duan, Hongbing
    Ke, Sunkui
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (03) : 1597 - 1613
  • [46] Efficacy and Safety Assessment of Paclitaxel in Patients with Docetaxel-Resistant Esophageal Squamous Cell Carcinoma
    Imai, Hiroo
    Komine, Keigo
    Takahashi, Shin
    Saijo, Ken
    Okada, Yoshinari
    Kobayashi, Akihiro
    Okita, Akira
    Chikamatsu, Sonoko
    Kasahara, Yuki
    Takahashi, Masahiro
    Oishi, Takayuki
    Shirota, Hidekazu
    Takahashi, Masanobu
    Shimodaira, Hideki
    Ishioka, Chikashi
    CHEMOTHERAPY, 2015, 61 (05) : 262 - 268
  • [47] EFFICACY AND SAFETY OF CHEMORADIOTHERAPY FOR PATIENTS WITH LOCOREGIONAL LYMPH NODE RECURRENCE OF ESOPHAGEAL SQUAMOUS CELL CARCINOMA
    Funakoshi, T.
    Tsushima, T.
    Shibata, Y.
    Tabuse, H.
    Sawai, H.
    Hamauchi, S.
    Taniguchi, H.
    Todaka, A.
    Yokota, T.
    Machida, N.
    Yamazaki, K.
    Fukutomi, A.
    Yasui, H.
    Onozawa, Y.
    Boku, N.
    ANNALS OF ONCOLOGY, 2012, 23 : 138 - 138
  • [48] ASO Author Reflections: Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma
    Chan, Wing-Lok
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (02) : 871 - 872
  • [49] The efficacy and safety of neoadjuvant camrelizumab and chemotherapy for locally advanced thoracic esophageal squamous cell carcinoma
    Xu, Weili
    Jiang, Youhua
    Wang, Changchun
    Wu, Jie
    Li, Jianqiang
    Hu, Yuqian
    Lu, Weishan
    Shen, Dijian
    Wang, Yinjie
    Chen, Qixun
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [50] Clinical efficacy and safety of apatinib as maintenance treatment in patients with advanced esophageal squamous cell carcinoma
    Liu, Guohui
    Wang, Yanbo
    Wang, Chunbo
    He, Yunlong
    Mingyan, E.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (12) : 1423 - 1430
12345